pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›ASP-001.1
drug · small molecule
save

ASP-001.1

Phase 1updated 3mo ago
by Aspargo Laboratories Inc🔗 ChEMBL
Phase 1
community read0 votes

🐶 often sniffed alongside

top 7
  • tagApproval2 co-mentions · 1 sources
  • drugVYBRIQUE2 co-mentions · 1 sources
  • drugsildenafil citrate1 co-mentions · 1 sources
  • drugRevatio1 co-mentions · 1 sources
  • drugViagra1 co-mentions · 1 sources
  • tagSmall Molecule1 co-mentions · 1 sources
  • drugsildenafil citrate SR1 co-mentions · 1 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 30 investigational indications.

targets

cGMP-specific 3',5'-cyclic phosphodiesterase

all catalysts(0)

nothing on the calendar yet

Trials studying ASP-001.1

  • phase1Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subjectnot yet recruitingn=72
  • phase1The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjectsrecruitingn=12

News(1)

  • A year after Vertex’s big launch, pain drug research faces a pivotal moment
    Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?
    biopharma_dive · 3mo ago
trade names
Granpidam, Liqrev, Mysildecard, Nipatra, Patrex, Revatio
generic
sildenafil citrate
MOA
Phosphodiesterase 5A inhibitor
indication
Erectile Dysfunction
phase
phase_1
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 6m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?